Literature DB >> 19304531

[Expression of ERK5 in multidrug-resistant hepatocellular carcinoma cell line].

Feng Yan1, Xiao-Min Wang, Chao Pan.   

Abstract

OBJECTIVE: To detect the expression of extracellular-signal regulated protein kinase 5 (ERK5) in multidrug-resistant hepatocellular carcinoma cell lines hepG2/ADM and BEL-7402/5-FU and in the parental cell lines (hepG2 and BEL-7402), and study the role of ERK5 in multidrug resistance of hepatocellular carcinoma.
METHODS: MTT assay was used to determine the multidrug resistance (MDR) of hepG2/ADM and BEL-7402/5-FU cells. Real-time PCR and Western blotting were used to detect the expression of ERK5 at mRNA and protein levels in the 4 cell lines.
RESULTS: The resistance indices to ADM, 5-FU, and CDDP was 12.34, 5.74, and 3.81 in hepG2/ADM cells, and the resistance indices to 5-FU, VCR, OHP, MTX, and ADM was 15.32, 10.08, 5. 85, 6.74 and 3.26 in BEL-7402 cells, respectively. Compared with those in hepG2 and BEL-7402 cells, the ERK5 gene was up-regulated at both mRNA and protein levels in HepG2/ADM cells, but down-regulated at the mRNA level and up-regulated at the protein level in BEL-7402/5-FU cells.
CONCLUSIONS: ERK5 is related to multidrug resistance in HepG2/ADM and BEL-7402/5-FU cells, and may provide new clues for reversing multidrug resistance of hepatocellular carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19304531

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  4 in total

1.  Mitogen/extracellular signal-regulated kinase kinase-5 promoter region polymorphisms affect the risk of sporadic colorectal cancer in a southern Chinese population.

Authors:  Dechang Diao; Lei Wang; Jun-Xiao Zhang; Dianke Chen; Huanliang Liu; Yisheng Wei; Jiachun Lu; Junsheng Peng; Jianping Wang
Journal:  DNA Cell Biol       Date:  2011-08-23       Impact factor: 3.311

2.  Extracellular signal-regulated kinase 5: a potential therapeutic target for malignant mesotheliomas.

Authors:  Arti Shukla; Jill M Miller; Christopher Cason; Mutlay Sayan; Maximilian B MacPherson; Stacie L Beuschel; Jedd Hillegass; Pamela M Vacek; Harvey I Pass; Brooke T Mossman
Journal:  Clin Cancer Res       Date:  2013-02-27       Impact factor: 12.531

3.  MEK5 overexpression is associated with the occurrence and development of colorectal cancer.

Authors:  Dechang Diao; Lei Wang; Jin Wan; Zhiqiang Chen; Junsheng Peng; Huanliang Liu; Xinlin Chen; Wei Wang; Liaonan Zou
Journal:  BMC Cancer       Date:  2016-05-09       Impact factor: 4.430

4.  Establishment of a nine-gene prognostic model for predicting overall survival of patients with endometrial carcinoma.

Authors:  Jianchao Ying; Qian Wang; Teng Xu; Jianxin Lyu
Journal:  Cancer Med       Date:  2018-04-17       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.